quinazolines has been researched along with Myocardial Ischemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (80.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durand, JB; Kim, P; Yusuf, SW | 1 |
| Deng, HW; Hu, CP; Li, YJ; Xiao, L | 1 |
| Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, J | 1 |
| Kitada, M; Mori, H; Takahashi, K; Tanabe, T; Usui, K | 1 |
| Adachi, H; Kodama, K; Mori, N; Saito, I | 1 |
| Handa, S; Kitada, M; Mori, H; Takahashi, K; Tanabe, T; Yoshioka, K | 1 |
| Hoeft, A; Kazmaier, S; Sonntag, H; Stephan, H | 1 |
| Kono, M; Morita, S; Rubsamen, R | 1 |
| Nasa, Y; Takeo, S; Yabe, K | 1 |
| Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M | 1 |
| Folkes, A; Nutting, C | 1 |
| Handa, S; Mori, H; Shinozaki, Y; Tanabe, T; Usui, K | 1 |
| Kurz, T; Richardt, G; Schneider, I; Tölg, R | 1 |
| Hata, K; Kloner, RA; Przyklenk, K; Whittaker, P | 1 |
| Janssen, PA; Reneman, RS; Van de Water, A; Xhonneux, R | 1 |
1 trial(s) available for quinazolines and Myocardial Ischemia
| Article | Year |
|---|---|
Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
Topics: Adult; Aged; Cardiotonic Agents; Catecholamines; Coronary Circulation; Enoximone; Heart; Hemodynamics; Humans; Imidazoles; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Phosphodiesterase Inhibitors; Quinazolines; Vasodilator Agents; Ventricular Function, Left | 1994 |
14 other study(ies) available for quinazolines and Myocardial Ischemia
| Article | Year |
|---|---|
Erlotinib or gefitinib for non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Myocardial Ischemia; Protein Kinase Inhibitors; Quinazolines; Stroke | 2011 |
The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts.
Topics: Alkaloids; Animals; Calcitonin Gene-Related Peptide; Cardiotonic Agents; Creatine Kinase; Dose-Response Relationship, Drug; Evodia; Fruit; Guinea Pigs; Heart Ventricles; Indole Alkaloids; Male; Molecular Structure; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Plants, Medicinal; Quinazolines; Radioimmunoassay; Receptors, Drug; Ventricular Pressure | 2002 |
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Drug Administration Schedule; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Quinazolines; Urination Disorders | 2006 |
Effects of bunazosin, a selective alpha 1-blocking agent, and propranolol used alone and in combination on canine ventricular refractoriness and its dispersion during myocardial ischemia.
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Circulation; Dogs; Drug Therapy, Combination; Electrocardiography; Injections, Intravenous; Myocardial Ischemia; Propranolol; Quinazolines | 1993 |
Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs.
Topics: Animals; Drug Interactions; Electrocardiography; Guinea Pigs; Injections, Intravenous; Isosorbide Dinitrate; Male; Myocardial Ischemia; Niacinamide; Nicorandil; Nitro Compounds; Phosphodiesterase Inhibitors; Piperidines; Quinazolines; Vasodilator Agents; Vasopressins | 1994 |
Effects of sympathetic stimulation, with and without previous alpha 1 and beta adrenoceptor blockade, on refractoriness dispersion in canine heart.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Electrophysiology; Heart; Myocardial Ischemia; Propranolol; Quinazolines; Stimulation, Chemical; Sympathetic Nervous System | 1994 |
Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Prazosin; Propranolol; Prospective Studies; Quinazolines; Random Allocation; Yohimbine | 1995 |
Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Creatine Kinase; Heart; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Phenylephrine; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Timolol; Ventricular Function, Left | 1997 |
Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Dogs; Endocardium; Heart Ventricles; Myocardial Ischemia; Pericardium; Propranolol; Quinazolines; Receptors, Adrenergic, alpha-1; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function | 1997 |
The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Enzyme Inhibitors; Female; Fluorouracil; Humans; Middle Aged; Myocardial Ischemia; Quinazolines; Thiophenes; Thymidylate Synthase | 1999 |
Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Dogs; Electrocardiography; Endocardium; Heart; Myocardial Ischemia; Pericardium; Propranolol; Quinazolines; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Ventricular Fibrillation | 1998 |
Alpha 1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Chromatography, Thin Layer; Desipramine; Diacylglycerol Kinase; Diglycerides; Estrenes; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Norepinephrine; Perfusion; Phosphatidic Acids; Piperidines; Prazosin; Propranolol; Pyrrolidinones; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Time Factors; Type C Phospholipases | 1999 |
Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries.
Topics: Adenosine; Animals; Blood Platelets; Carotid Artery Thrombosis; Carotid Stenosis; Dogs; Myocardial Ischemia; Quinazolines; Rabbits; Receptors, Purinergic P1; Triazoles; Vascular Patency | 1999 |
Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.
Topics: Animals; Blood Pressure; Cardiac Output, Low; Dogs; Female; Heart Rate; Hemodynamics; Imidazoles; Infusions, Intravenous; Male; Milrinone; Myocardial Ischemia; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Vascular Resistance; Ventricular Function, Left | 1992 |